I'm Stu McAfee, PhD. I received my B.S. in Neuroscience from the University of Texas at Dallas, and my PhD in Neuroscience from University of Tennessee Health Science Center in Memphis. I am an active member of the Posterior Fossa Society, a collective of clinicians and researchers devoted to improving research and care for pediatric brain tumor patients who experience severe surgical complications.
Following tumor removal for medulloblastoma, approximately one in four children develop deficits in speech, movement and affect – a condition called posterior fossa syndrome (PFS) or cerebellar mutism syndrome. PFS is one of the most devastating survivorship outcomes for those with posterior fossa tumors, and my research focuses on understanding the etiology of PFS and developing risk assessment tools to identify those at high risk for developing this condition.
I'm Stu McAfee, PhD. I received my B.S. in Neuroscience from the University of Texas at Dallas, and my PhD in Neuroscience from University of Tennessee Health Science Center in Memphis. I am an active member of the Posterior Fossa Society, a collective of clinicians and researchers devoted to improving research and care for pediatric brain tumor patients who experience severe surgical complications.
Following tumor removal for medulloblastoma, approximately one in four children develop deficits in speech, movement and affect – a condition called posterior fossa syndrome (PFS) or cerebellar mutism syndrome. PFS is one of the most devastating survivorship outcomes for those with posterior fossa tumors, and my research focuses on understanding the etiology of PFS and developing risk assessment tools to identify those at high risk for developing this condition.